2013 parkinson's disease glutathione 2013 four authors

2013 parkinson's disease glutathione 2013 four authors G6PD deficiency triggers dopamine loss and the initiation of pathogenesis: Cell Reports Frontiers | Metabolic Parkinson's disease

Name: 2013 parkinson's disease glutathione 2013 four authors G6PD deficiency triggers dopamine loss and the initiation of pathogenesis: Cell Reports Frontiers | Metabolic Parkinson's disease
Brand: metron-ms.com
SKU: 87018442794
Price: 26.04 USD
Availability: InStock
Rating: 4.4122 (14 reviews)

Frontiers Metabolic Parkinson's disease Gut microbiota and Parkinson's disease: exploring pathogenesis and potential therapeutic strategies from a gut brain axis perspective ScienceDirect Parkinson's disease and glucose metabolism impairment Translational Neurodegeneration Springer Nature Link Parkinson's Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical Translation Targeting Ferroptosis in Parkinson's Disease: Mechanisms and Emerging Therapeutic Strategies

SKU: 87018442794 · From metron-ms.com

4.4

USD26.04 USD59.04

Pay in 4 interest-free payments of $6.51 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 4 - Aug 9

Description

Taylor & Francis, Washington, DC

Moreover, the UA transportersURAT1, GLUT9, and ABCG2play crucial roles in regulating UA levels, with dysfunctional transporters leading to abnormal serum UA levels, as observed in hypouricemia and hyperuricemia

Lamotrigine, with a half-life of 2337 hours, and desvenlafaxine, with a half-life of about 10 hours, are examples of drugs that show linear pharmacokinetics